Vanguard Group Inc. Increases Stake in Intuitive Surgical, Inc. $ISRG

Vanguard Group Inc. raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.1% in the second quarter, Holdings Channel reports. The firm owned 33,335,833 shares of the medical equipment provider’s stock after acquiring an additional 670,302 shares during the quarter. Vanguard Group Inc. owned 0.09% of Intuitive Surgical worth $18,115,025,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Tobam lifted its position in Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares in the last quarter. TD Capital Management LLC raised its stake in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the last quarter. 1248 Management LLC bought a new position in shares of Intuitive Surgical during the first quarter valued at $30,000. Princeton Global Asset Management LLC bought a new stake in Intuitive Surgical in the 2nd quarter worth about $30,000. Finally, Bank of Jackson Hole Trust increased its holdings in Intuitive Surgical by 70.5% in the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 31 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, EVP Brian Edward Miller sold 3,500 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the sale, the executive vice president directly owned 5,758 shares of the company’s stock, valued at $3,310,850. This represents a 37.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Craig H. Barratt sold 750 shares of the firm’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $435,000.00. The SEC filing for this sale provides additional information. Insiders sold 116,164 shares of company stock valued at $61,916,172 in the last ninety days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $546.71 on Tuesday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The firm’s 50 day moving average price is $484.04 and its 200-day moving average price is $503.21. The stock has a market cap of $195.98 billion, a P/E ratio of 72.32, a PEG ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. During the same period last year, the company posted $1.84 earnings per share. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. Evercore ISI upped their target price on shares of Intuitive Surgical from $450.00 to $540.00 in a research note on Wednesday, October 22nd. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. BTIG Research raised their target price on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research report on Wednesday, October 22nd. Finally, Piper Sandler increased their price target on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.